DOI: https://doi.org/10.36347/sasjs.2026.v12i05.013

Pages: 403-408

Background: Gastric cancer is the third leading cause of cancer mortality worldwide. Standard treatment includes gastrectomy with lymphadenectomy and chemotherapy, but carries high morbidity. Enhanced Recovery After Surgery (ERAS) improves outcomes by reducing surgical stress, complications, hospital stay, costs, and enhancing recovery and patient satisfaction. Objectives: To evaluate the safety and effectiveness of the ERAS protocol following gastric resection for carcinoma of the stomach. Methods: This prospective study was conducted in the Department of Surgery at Shaheed Suhrawardy Medical College & Hospital, Dhaka, Bangladesh, from February 2020 to July 2020. A total of 50 patients undergoing gastric resection were included and followed to assess early postoperative outcomes. Preoperative and postoperative evaluations included clinical history, physical examination, and relevant investigations. Data were recorded in structured case forms and analyzed using SPSS version 20.0. Results: The majority of patients (54%) were aged 51-60 years, with a mean age of 52.30±9.17 years; 72% were male. Hypertension (58%) was the most common comorbidity. Most patients were ASA II (64%). Laparoscopic surgery was performed in 82% of cases. The overall postoperative complication rate was 8%, including bowel obstruction (2%), anastomotic leak (2%), and wound infection (4%). The mean postoperative hospital stay was 5.37±0.63 days. Conclusion: The ERAS protocol following gastric surgery is safe and effective, resulting in faster recovery, fewer complications, and a reduced hospital stay. It is feasible and beneficial in our clinical setting.